Institutional Review Board Statement
This study was approved by the local Ethics and Research Committee under 4,546,726 and registered in the Brazilian Platform for the Registration of Clinical Trials (ReBEC) under the registration: RBR-4mxg57b, fully following the Declaration of Helsinki.